Biodesix, Inc. BDSX Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Biodesix, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Biodesix, Inc.'s return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Biodesix, Inc.'s return on equity?
- Biodesix, Inc. (BDSX) reported return on equity of -316.5% in Q1 2026.
- What is the long-term trend for Biodesix, Inc.'s return on equity?
- Over 3 years (2021 to 2024), Biodesix, Inc.'s return on equity has grown at a 33.5% compound annual growth rate (CAGR), from -141.8% to -337.3%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.